(firstQuint)First Time in Human Study.

 To evaluate the safety, tolerability and pharmacokinetics of single ascending doses of GSK356278 and may assess the effect of food on GSK356278 pharmacokinetics.

 They study will assess the compound's effect on nausea, emesis and alertness.

 Close monitoring of cardiovascular parameters will be included.

.

 First Time in Human Study@highlight

This study will evaluate the safety, tolerability, and pharmacokinetics of GSK356278 in male volunteers